NorthWest Biotherapeutics Inc (NWBO)

[AVII77]

And since I have it handy, here is another comparison I made using data from a German trial in MGMT+ patients published in Lancet in 2019.

I made this in the same way I made the other graphical comparison.

In Black is the DCVax data from Fig 2b of Liau's JTM paper. IU didn't get the y-axis perfect here, but again, the error benefits DCVax curve (It should be shifted down a smidgen more).

The DCVax MGMT+ data does not look much different from the German trial SOC.